Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 6, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

Screening for depression in post stroke patients.

Sophia Ul Haq1, Christopher Symeon, Mark Agius

  • 1South Essex University Partnership NHS Trust, UK.

Psychiatria Danubina
|November 9, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A DESCRIPTION OF ADDISON'S DISEASE, AND ITS NEUROPSYCHIATRIC MANIFESTATIONS COMPARING THE DISEASE AS IT IS NOW TO THE DISEASE AS EXPERIENCED BY SAINT ELIZABETH OF THE TRINITY IN 1906.

Psychiatria Danubina·2025
Same author

WHY IS IT IMPORTANT TO STAGE CASES OF SCHIZOPHRENIA?

Psychiatria Danubina·2025
Same author

LESSONS TO BE LEARNT FROM THE UNFORTUNATE CASE OF THE DEATH OF MOLLY RUSSELL.

Psychiatria Danubina·2025
Same author

THE DEATH OF VICTIMS AS A RESULT OF SCHIZOPHRENIA OR OTHER SERIOUS MENTAL ILLNESS; WHAT HAVE WE LEARNT OVER THE YEARS?

Psychiatria Danubina·2025
Same author

HOW SHOULD A DOCTOR REACT WHEN PERSONS EXPRESS A WISH TO SUFFER IN UNION WITH CHRIST? TRUE LOVE AND AN IMPORTANT ISSUE OF NEUROSCIENCE.

Psychiatria Danubina·2025
Same author

SAINT JOHN OF THE CROSS AND THE DEVOTION OF THE NAZZARENO OR REDENTUR; THE STORY OF HOW A SINGLE LOCUTION OR THOUGHT SPREAD ACROSS THE WORLD THROUGH EMBODIED COGNITION AND NEUROSCIENCE.

Psychiatria Danubina·2025

Post-stroke depression is common, affecting up to 56% of patients. Implementing formal screening tools like the PHQ-9 significantly improves identification rates for depression in stroke survivors.

Area of Science:

  • Neurology
  • Psychiatry
  • Public Health

Background:

  • Depression significantly impacts stroke survivors, with prevalence rates ranging from 25-54%.
  • Current practices for identifying and managing depression in post-stroke patients lack formal screening tools.
  • Adherence to established guidelines, such as those from NICE, is crucial for effective patient care.

Purpose of the Study:

  • To determine the prevalence of depression in post-stroke patients.
  • To evaluate the methods used for identifying depression in this population.
  • To assess the treatment and medication patterns for depression in stroke survivors.

Main Methods:

  • A two-phase audit was conducted to assess depression screening and management.
  • Phase 1 involved an initial audit of current practices.

More Related Videos

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients
05:23

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients

Published on: March 11, 2021

Related Experiment Videos

Last Updated: Jun 6, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients
05:23

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients

Published on: March 11, 2021

  • Phase 2 introduced the Patient Health Questionnaire-9 (PHQ-9) as a screening tool, followed by a re-audit after four months.

    • Main Results:

    • Phase 1 revealed a depression prevalence of 28%, with inadequate documentation of mood assessment.
    • Thirteen of 60 patients received psychotropic medications.
    • In Phase 2, using the PHQ-9, 56% of screened patients indicated depression, with scores ranging from mild to moderately severe.

    Conclusions:

    • The initial audit highlighted the absence of formal depression screening in post-stroke care, aligning with lower-end prevalence rates.
    • Introduction of the PHQ-9 screening tool led to a doubling of identified depression cases, from 28% to 56%.
    • Formal screening is essential for accurately identifying depression in stroke patients and ensuring adherence to clinical guidelines.